Status:
COMPLETED
Myocardial Perfusion Imaging in Liver Transplantation Candidates
Lead Sponsor:
University Hospital Birmingham NHS Foundation Trust
Conditions:
Myocardial Perfusion Imaging
Liver Failure
Eligibility:
All Genders
18+ years
Brief Summary
The optimal screening strategy for assessment of coronary artery disease in patients with end-stage liver disease (ESLD) is unclear. Although consensus based guidelines support noninvasive stress test...
Detailed Description
Controversy over whether SPECT imaging offers clinical utility in ESLD has been fuelled by conflicting reports on its accuracy to diagnose CAD in this setting. Moreover, there are no studies examining...
Eligibility Criteria
Inclusion
- • Liver transplantation candidates with one or more of the following:
- inability to perform \>4 METs by history
- insulin-treated diabetes mellitus
- serum creatinine \>152μmol/l
- history of MI, PCI or CABG
- stable angina
- cerebrovascular disease
- peripheral vascular disease
Exclusion
- Age \< 18 years
- Pregnancy
- Contraindication to liver transplantation
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
403 Patients enrolled
Trial Details
Trial ID
NCT03864497
Start Date
September 1 2007
End Date
June 1 2019
Last Update
June 19 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.